A 'Whole Different Ballgame' for Myeloma Treatment
The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects.
Stay updated with breaking news from David Avigan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects.
The first documented case of pancreatic cancer dates back to the 18th century. Since then, researchers have undertaken a protracted and challenging odyssey to understand the elusive and deadly disease. To date, there is no better cancer treatment tha
PRISM, developed by MIT CSAIL, is a pancreatic cancer risk prediction model using a vast, federated network of electronic health records from numerous U.S. healthcare organizations.
BIDMC held its 16th annual Cancer Center Symposium, focusing on targeted and immune-based cancer therapy. Learn more about this event.